Shares in UK drugmaker GSK (GSK) gained 2% after the company confirmed its FY26 guidance. In contrast, shares in Danish drugmaker Novo Nordisk plummeted 18% after the firm predicted a drop in sales in 2026. GSK share price: £19.85 (+2%) PE: 14x Market cap: £78.3bn Yield: 3.3% POSITIVE PROGRESS AT GSK GSK reported an increase … Continue reading GSK gains while Novo Nordisk shares plummet